本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Rocket Pharmaceuticals, Inc.

3.31
+0.04001.22%
成交量:139.91萬
成交額:461.35萬
市值:3.58億
市盈率:-1.48
高:3.36
開:3.27
低:3.22
收:3.27
52周最高:11.11
52周最低:2.19
股本:1.08億
流通股本:7,878.63萬
量比:0.84
換手率:1.78%
股息:- -
股息率:- -
每股收益(TTM):-2.2397
每股收益(LYR):-2.7292
淨資產收益率:-74.88%
總資產收益率:-40.56%
市淨率:1.14
市盈率(LYR):-1.21

資料載入中...

公司資料

公司名字:
Rocket Pharmaceuticals, Inc.
交易所:
NASDAQ
成立時間:
1999
員工人數:
299
公司地址:
9 Cedarbrook Drive,Cranbury,New Jersey,United States
郵編:
08512
電話:
傳真:
- -
簡介:
Rocket Pharmaceuticals, Inc.於1999年7月7日根據特拉華州法律註冊成立。該公司是一家完全整合的、處於後期階段的生物技術公司,專註於開發首創、唯一和同類最佳的基因療法,具有直接的靶向作用機制和明確的臨床終點,用於罕見和破壞性疾病。

董事

名稱
職位
Gaurav D. Shah
Director and Chief Executive Officer
Roderick Wong
Chairman of the Board
Carsten Boess
Independent Director
David P. Southwell
Independent Director
Elisabeth Bjork
Independent Director
Fady Ibraham Malik
Independent Director
Mikael Dolsten
Director
Peter Fong
Director
Piratip Pratuwan
Director

股東

名稱
職位
Gaurav D. Shah
Director and Chief Executive Officer
Christopher Stevens
Chief Operating Officer
Martin Wilson
Interim Principal Financial Officer,Chief Corporate Officer, Senior Vice President and General Counsel
John Militello
Vice President, Finance, Treasurer and Principal Accounting Officer
Jonathan Schwartz
Chief Medical Officer and Chief Gene Therapy Officer
Sarbani Chaudhuri
Chief Commercial Officer and Chief Medical Affairs Officer